LEXINGTON, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a ...

Restructuring is not just about survival; it’s about thriving and positioning yourself for future success. Whether driven by technological advancements, market shifts, or organizational strategy ...

Go-forward strategy will emphasize topline revenue growth and future profitability. Company to reduce total operating costs by an estimated 15% in fiscal year 2025. The restructuring will allow ...

iRobot transferred all of its equity to Shenzhen Picea Robotics and said it will launch a U.S. subsidiary to protect U.S. consumer data as it emerges from the chapter 11 bankruptcy process The maker ...

Prime Medicine announces positive Phase 1/2 data for PM359, leadership changes, and strategic pipeline prioritization, focusing on liver diseases. Prime Medicine, Inc. announced initial positive data ...